Trials / Completed
CompletedNCT00703313
Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active Comparators
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 72 (estimated)
- Sponsor
- Santen Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to compare the concentration in human tears of levofloxacin and the active comparators at 15 minutes, 2,6, 12, and 24 hours after instillation of a single drop of medication.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 1.5% levofloxacin ophthalmic solution | 1 drop instilled at each visit |
| DRUG | 0.5% moxifloxacin hydrochloride ophthalmic solution | 1 drop instilled at each visit |
| DRUG | 0.3% gatifloxacin ophthalmic solution | 1 drop instilled at each visit |
Timeline
- Start date
- 2008-05-01
- Primary completion
- 2008-06-01
- First posted
- 2008-06-23
- Last updated
- 2009-02-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00703313. Inclusion in this directory is not an endorsement.